Safety and tolerability of repeated sessions of deep transcranial magnetic stimulation in obesity

Endocrine - Tập 71 - Trang 331-343 - 2020
Anna Ferrulli1,2, Stefano Massarini2, Concetta Macrì2, Livio Luzi1,2
1Department of Biomedical Sciences for Health, University of Milan, Milan, Italy
2Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS MultiMedica, Sesto San Giovanni, MI, Italy

Tóm tắt

Repetitive Transcranial Magnetic Stimulation (rTMS) has been demonstrated to be effective in body weight control in individuals with obesity. Most clinical trials on rTMS provided a reassuring safety profile. In the present work, we present an extensive analysis on both severe and mild Adverse Events (AEs) in obese individuals treated with rTMS. We examined the intensity, duration, correlation with the treatment, up to 1 year after the end of rTMS treatment. Descriptive analysis included a total of 63 subjects undergoing a 5-week deep rTMS experimental treatment for obesity (age 48.3 ± 10.4 years; BMI 36.3 ± 4.4 kg/m2): 31 patients were treated with high-frequency rTMS (HF), 13 with low-frequency rTMS (LF), and 19 were sham treated (Sham). Thirty-two subjects (50.8%) reported a total of 52 AEs, including mainly moderate (51.9%) events. The most frequently reported side effects were headaches of moderate intensity (40.4%) and local pain/discomfort (19.2%) and resulted significantly more frequent in HF group compared to other groups (p < 0.05). No significant differences among groups were found for the other reported AEs: drowsiness, insomnia, paresthesia, vasovagal reactions, hypertensive crisis. No AEs potentially related to the rTMS arised up to 1 year from the end of the treatment. This is the first comprehensive safety analysis in obese patients treated with rTMS. The analysis did not reveal any unexpected safety concerns. Only headaches and local pain/discomfort have been significantly more frequent in the HF group, confirming the good tolerability of rTMS even in the obese population potentially more susceptible to side effects of brain stimulation.

Tài liệu tham khảo

S. Rossi, M. Hallett, P.M. Rossini, A. Pascual-Leone, Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 120, 2008–2039 (2009). https://doi.org/10.1016/j.clinph.2009.08.016 G.S. Pell, Y. Roth, A. Zangen, Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation: influence of timing and geometrical parameters and underlying mechanisms. Prog. Neurobiol. 93, 59–98 (2011). https://doi.org/10.1016/j.pneurobio.2010.10.003 M. Lu, S. Ueno, Comparison of the induced fields using different coil configurations during deep transcranial magnetic stimulation. PLoS ONE 12, e0178422 (2017). https://doi.org/10.1371/journal.pone.0178422 M. Nadeem, T. Thorlin, O.P. Gandhi, M. Persson, Computation of electric and magnetic stimulation in human head using the 3-D impedance method. IEEE Trans. Biomed. Eng. 50, 900–907 (2003). https://doi.org/10.1109/TBME.2003.813548 Y. Levkovitz, Y. Roth, E.V. Harel, Y. Braw, A. Sheer, A. Zangen, A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin. Neurophysiol. 118, 2730–2744 (2007). https://doi.org/10.1016/j.clinph.2007.09.061 M.S. George, F. Padberg, T.E. Schlaepfer, J.P. O’Reardon, P.B. Fitzgerald, Z.H. Nahas et al. Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder). Brain. Stimul. 2, 14–21 (2009). https://doi.org/10.1016/j.brs.2008.06.001 D.A. Gorelick, A. Zangen, M.S. George, Transcranial magnetic stimulation in the treatment of substance addiction. Ann. N.Y. Acad. Sci. 1327, 79–93 (2014). https://doi.org/10.1111/nyas.12479 M. Diana, T. Raij, M. Melis, A. Nummenmaa, L. Leggio, A. Bonci, Rehabilitating the addicted brain with transcranial magnetic stimulation. Nat. Rev. Neurosci. 18, 685–693 (2017). https://doi.org/10.1038/nrn.2017.113 K.K. Kedzior, I. Gerkensmeier, M. Schuchinsky, Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review. BMC Psychiatry 18, 137 (2017). https://doi.org/10.1186/s12888-018-1704-0 R. Bou Khalil, C. El Hachem, Potential role of repetitive transcranial magnetic stimulation in obesity. Eat. Weight Disord. 19, 403–407 (2014). https://doi.org/10.1007/s40519-013-0088-x A. Ferrulli, C. Macrì, I. Terruzzi, S. Massarini, F. Ambrogi, M. Adamo, V. Milani, L. Luzi, Weight loss induced by deep transcranial magnetic stimulation in obesity: a randomized, double-blind, sham-controlled study. Diabetes Obes. Metab. 21, 1849–1860 (2019). https://doi.org/10.1111/dom.13741 P. Duriez, R. Bou Khalil, Y. Chamoun, R. Maatoug, R. Strumila, M. Seneque et al. Brain stimulation in eating disorders: state of the art and future perspectives. J. Clin. Med. 9, E2358 (2020). https://doi.org/10.3390/jcm9082358 J.P. Lefaucheur, N. André-Obadia, A. Antal, S.S. Ayache, C. Baeken, D.H. Benninger et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin. Neurophysiol. 125, 2150–2206 (2014). https://doi.org/10.1016/j.clinph.2014.05.021 K. Machii, D. Cohen, C. Ramos-Estebanez, A. Pascual-Leone, Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin. Neurophysiol. 117, 455–471 (2006). https://doi.org/10.1016/j.clinph.2005.10.014 C.K. Loo, T.F. McFarquhar, P.B. Mitchell, A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int. J. Neuropsychopharmacol. 11, 131–147 (2008). https://doi.org/10.1017/S1461145707007717 P.G. Janicak, J.P. O’Reardon, S.M. Sampson, M.M. Husain, S.H. Lisanby, J.T. Rado et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J. Clin. Psychiatry 69, 222–232 (2008). https://doi.org/10.4088/jcp.v69n0208 A.J. Lerner, E.M. Wassermann, D.I. Tamir, Seizures from transcranial magnetic stimulation 2012–2016: results of a survey of active laboratories and clinics. Clin. Neurophysiol. 130, 1409–1416 (2019). https://doi.org/10.1016/j.clinph.2019.03.016 E.M. Wassermann, Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation. Electroencephalogr. Clin. Neurophysiol. 108, 1–16 (1998). https://doi.org/10.1016/s0168-5597(97)00096-8. June 5–7, 1996 R. Taylor, V. Galvez, C. Loo, Transcranial magnetic stimulation (TMS) safety: a practical guide for psychiatrists. Australas. Psychiatry 26, 189–192 (2018). https://doi.org/10.1177/1039856217748249 T.M. Kesar, H.S. McDonald, S.P. Eicholtz, M.R. Borich, Case report of syncope during a single pulse transcranial magnetic stimulation experiment in a healthy adult participant. Brain Stimul. 9, 471–472 (2016). https://doi.org/10.1016/j.brs.2016.03.013. B.T. Gillick, T. Rich, M. Chen, G.D. Meekins, Case report of vasovagal syncope associated with single pulse transcranial magnetic stimulation in a healthy adult participant. BMC Neurol. 15, 248 (2015). https://doi.org/10.1186/s12883-015-0510-2 J. Van Dam, M. Goldsworthy, Case report of a vasovagal pre-syncope event during single-pulse transcranial magnetic stimulation in a healthy adult participant. Clin. Neurophysiol. 131, 981–982 (2020). https://doi.org/10.1016/j.clinph.2019.12.401 P.E. Tarapore, T. Picht, L. Bulubas, Y. Shin, N. Kulchytska, B. Meyer, M.S. Berger, S.S. Nagarajan, S.M. Krieg, Safety and tolerability of navigated TMS for properative mapping in neurosurgical patients. Clin. Neurophysiol. 127, 1895–1900 (2016). https://doi.org/10.1016/j.clinph.2015.11.042 O.A. Tashani, R. Astita, D. Sharp, M.I. Johnson, Body mass index and distribution of body fat can influence sensory detection and pain sensitivity. Eur. J. Pain 21, 1186–1196 (2017). https://doi.org/10.1002/ejp.1019 A. Sachdev, M.J. Marmura, Metabolic syndrome and migraine. Front. Neurol. 3, 161 (2012). https://doi.org/10.3389/fneur.2012.00161 S. Narouze, D. Souzdalnitski, Obesity and chronic pain: systematic review of prevalence and implications for pain practice. Reg. Anesth. Pain Med. 40, 91–111 (2015). https://doi.org/10.1097/AAP.0000000000000218 D.S. McVinnie, Obesity and pain. Br. J. Pain 7, 163–170 (2013). https://doi.org/10.1177/2049463713484296 C. Brandt, M. Pedersen, A. Rinnov, A.S. Andreasen, K. Møller, P. Hojman et al. Obesity and low-grade inflammation increase plasma follistatin-like 3 in humans. Mediators Inflamm. 2014, 364209 (2014). https://doi.org/10.1155/2014/364209 H.K. Vincent, M.C. Adams, K.R. Vincent, R.W. Hurley, Musculoskeletal pain, fear avoidance behaviors, and functional decline in obesity: potential interventions to manage pain and maintain function. Reg. Anesth. Pain Med. 38, 481–491 (2013). https://doi.org/10.1097/AAP.0000000000000013 C. Krishnan, L. Santos, M.D. Peterson, M. Ehinger, Safety of noninvasive brain stimulation in children and adolescents. Brain. Stimul. 8, 76–87 (2015). https://doi.org/10.1016/j.brs.2014.10.012 D.M. Blumberger, F. Vila-Rodriguez, K.E. Thorpe, K. Feffer, Y. Noda, P. Giacobbe et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 391, 1683–1692 (2018). https://doi.org/10.1016/S0140-6736(18)30295-2 A.V. Peterchev, T.A. Wagner, P.C. Miranda, M.A. Nitsche, W. Paulus, S.H. Lisanby et al. Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices. Brain Stimul. 5, 435–553 (2012). https://doi.org/10.1016/j.brs.2011.10.001 S. Yang, M.C. Chang, Effect of repetitive transcranial magnetic stimulation on pain management: a systematic narrative review. Front. Neurol. 11, 114 (2020). https://doi.org/10.3389/fneur.2020.00114 L. Lan, X. Zhang, X. Li, X. Rong, Y. Peng, The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails. J. Headache Pain 18, 86 (2017). https://doi.org/10.1186/s10194-017-0792-4 Y. Feng, B. Zhang, J. Zhang, Y. Yin, Effects of non-invasive brain stimulation on headache intensity and frequency of headache attacks in patients with migraine: a systematic review and meta-analysis. Headache 59, 1436–1447 (2019). https://doi.org/10.1111/head.13645 U.K. Misra, J. Kalita, G.M. Tripathi, S.K. Bhoi, Is beta endorphin related to migraine headache and its relief? Cephalalgia 33, 316–322 (2013). https://doi.org/10.1177/0333102412473372 A. Ferrulli, C. Macrì, I. Terruzzi, F. Ambrogi, V. Milani, M. Adamo, L. Luzi, High frequency deep transcranial magnetic stimulation acutely increases β-endorphins in obese humans. Endocrine 64, 67–74 (2019). https://doi.org/10.1007/s12020-018-1791-1 P. Giraud, S. Chauvet, Migraine and obesity, is there a link? Rev. Neurol. 169, 413–418 (2013). https://doi.org/10.1016/j.neurol.2012.11.009 L. Maizey, C.P. Allen, M. Dervinis, F. Verbruggen, A. Varnava, M. Kozlov et al. Comparative incidence rates of mild adverse effects to transcranial magnetic stimulation. Clin. Neurophysiol. 124, 536–544 (2013). https://doi.org/10.1016/j.clinph.2012.07.024 N.P. Holmes, L. Meteyard, Subjective discomfort of TMS predicts reaction times differences in published studies. Front. Psychol. 9, 1989 (2018). https://doi.org/10.3389/fpsyg.2018.01989 S.K. Kessler, P.E. Turkeltaub, J.G. Benson, R.H. Hamilton, Differences in the experience of active and sham transcranial direct current stimulation. Brain Stimul. 5, 155e62 (2012). https://doi.org/10.1016/j.brs.2011.02.007 S.A. Counter, E. Borg, Analysis of the coil generated impulse noise in extracranial magnetic stimulation. Electroencephalogr. Clin. Neurophysiol. 85, 280–288 (1992). https://doi.org/10.1016/0168-5597(92)90117-t S. Tringali, X. Perrot, L. Collet, A. Moulin, Repetitive transcranial magnetic stimulation: hearing safety considerations. Brain Stimul. 5, 354–363 (2012). https://doi.org/10.1016/j.brs.2011.06.005 F. Cogiamanian, A.R. Brunoni, P.S. Boggio, F. Fregni, M. Ciocca, A. Priori, Non-invasive brain stimulation for the management of arterial hypertension. Med. Hypotheses 74, 332–336 (2010). https://doi.org/10.1016/j.mehy.2009.08.037 G. Gulli, C. Tarperi, A. Cevese, M. Acler, G. Bongiovanni, P. Manganotti, Effects of prefrontal repetitive transcranial magnetic stimulation on the autonomic regulation of cardiovascular function. Exp. Brain Res. 226, 265–271 (2013). https://doi.org/10.1007/s00221-013-3431-6 M. Cabrerizo, A. Cabrera, J.O. Perez, J. de la Rua, N. Rojas, Q. Zhou et al. Induced effects of transcranial magnetic stimulation on the autonomic nervous system and the cardiac rhythm. Sci. World J. 2014, 349718 (2014). https://doi.org/10.1155/2014/349718 A. Foerster, J.M. Schmitz, S. Nouri, D. Claus, Safety of rapid-rate transcranial magnetic stimulation: heart rate and blood pressure changes. Electroencephalogr. Clin. Neurophysiol. 104, 207–212 (1997). https://doi.org/10.1016/s0168-5597(97)00016-6 M. Jahanshahi, M.C. Ridding, P. Limousin, P. Profice, W. Fogel, D. Dressler et al. Rapid rate transcranial magnetic stimulation–a safety study. Electroencephalogr. Clin. Neurophysiol. 105, 422–429 (1997). https://doi.org/10.1016/s0924-980x(97)00057-x J. Jenkins, P.M. Shajahan, J.M. Lappin, K.P. Ebmeier, Right and left prefrontal transcranial magnetic stimulation at 1 Hz does not affect mood in healthy volunteers. BMC Psychiatry 2, 1 (2002). https://doi.org/10.1186/1471-244X-2-1 N. Yozbatiran, M. Alonso-Alonso, J. See, A. Demirtas-Tatlidede, D. Luu, R.R. Motiwala et al. Safety and behavioral effects of high-frequency repetitive transcranial magnetic stimulation in stroke. Stroke 40, 309–312 (2009). https://doi.org/10.1161/STROKEAHA.108.522144 F. Van den Eynde, A.M. Claudino, I. Campbell, L. Horrell, M. Andiappan, D. Stahl et al. Cardiac safety of repetitive transcranial magnetic stimulation in bulimic eating disorders. Brain Stimul. 4, 112–114 (2011). https://doi.org/10.1016/j.brs.2010.06.003 K. Udupa, T.N. Sathyaprabha, J. Thirthalli, K.R. Kishore, T.R. Raju, B.N. Gangadhar, Modulation of cardiac autonomic functions in patients with major depression treated with repetitive transcranial magnetic stimulation. J. Affect. Disord. 104, 231–236 (2007). https://doi.org/10.1016/j.jad.2007.04.002 S. Frank, S. Kullmann, R. Veit, Food related processes in the insular cortex. Front. Hum. Neurosci. 7, 499 (2013). https://doi.org/10.3389/fnhum.2013.00499 A. Terraneo, L. Leggio, M. Saladini, M. Ermani, A. Bonci, L. Gallimberti, Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: a pilot study. Eur. Neuropsychopharmacol. 26, 37–44 (2016). https://doi.org/10.1016/j.euroneuro.2015.11.011 S. Kumar, S. Singh, N. Kumar, R. Verma, The Effects of repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex in the treatment of migraine comorbid with depression: a Retrospective Open Study. Clin. Psychopharmacol. Neurosci. 16, 62–66 (2018). https://doi.org/10.9758/cpn.2018.16.1.62